These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8071874)

  • 1. 1-Methyl-4-phenylpyridinium-like neurotoxicity of a pyridinium metabolite derived from haloperidol: cell culture and neurotransmitter uptake studies.
    Bloomquist J; King E; Wright A; Mytilineou C; Kimura K; Castagnoli K; Castagnoli N
    J Pharmacol Exp Ther; 1994 Aug; 270(2):822-30. PubMed ID: 8071874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MPP(+)-like neurotoxicity of a pyridinium metabolite derived from haloperidol: in vivo microdialysis and in vitro mitochondrial studies.
    Rollema H; Skolnik M; D'Engelbronner J; Igarashi K; Usuki E; Castagnoli N
    J Pharmacol Exp Ther; 1994 Jan; 268(1):380-7. PubMed ID: 8301579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of haloperidol metabolites on neurotransmitter uptake and release: possible role in neurotoxicity and tardive dyskinesia.
    Wright AM; Bempong J; Kirby ML; Barlow RL; Bloomquist JR
    Brain Res; 1998 Mar; 788(1-2):215-22. PubMed ID: 9555021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic neurotoxicity of 1-methyl-4-phenylpyridinium analogs in cultured neurons: relationship to the dopamine uptake system and inhibition of mitochondrial respiration.
    Saporito MS; Heikkila RE; Youngster SK; Nicklas WJ; Geller HM
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1400-9. PubMed ID: 1312170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurochemical and toxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridine to rat serotonin neurons in dissociated cell cultures.
    Friedman LK; Mytilineou C
    J Pharmacol Exp Ther; 1990 May; 253(2):892-8. PubMed ID: 2338661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of cytotoxicity of a quaternary pyridinium metabolite of haloperidol (HP+) with neurotoxin N-methyl-4-phenylpyridinium (MPP+) towards cultured dopaminergic neuroblastoma cells.
    Fang J; Zuo D; Yu PH
    Psychopharmacology (Berl); 1995 Oct; 121(3):373-8. PubMed ID: 8584620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a quaternary pyridinium metabolite of haloperidol (HP+) on the viability and catecholamine levels of cultured PC12 cells.
    Fang J; Yu PH
    Can J Physiol Pharmacol; 1997 Aug; 75(8):996-1000. PubMed ID: 9360014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzyme-catalyzed bioactivation of cyclic tertiary amines to form potential neurotoxins.
    Castagnoli N; Castagnoli KP; Van der Schyf CJ; Usuki E; Igarashi K; Steyn SJ; Riker RR
    Pol J Pharmacol; 1999; 51(1):31-8. PubMed ID: 10389142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of brain vesicular monoamine transporter (VMAT2) enhances 1-methyl-4-phenylpyridinium neurotoxicity in vivo in rat striata.
    Staal RG; Sonsalla PK
    J Pharmacol Exp Ther; 2000 May; 293(2):336-42. PubMed ID: 10773000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotoxicity studies with the monoamine oxidase B substrate 1-methyl-3-phenyl-3-pyrroline.
    Ogunrombi MO; Malan SF; Terre'Blanche G; Castagnoli K; Castagnoli N; Bergh JJ; Petzer JP
    Life Sci; 2007 Jul; 81(6):458-67. PubMed ID: 17655878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrastriatal infusion of the Parkinsonian neurotoxin, MPP(+), induces damage of striatal cell nuclei in Sprague-Dawley rats.
    Banerjee R; Sreetama S; Saravanan KS; Chandra G; Nath De S; Mohanakumar KP
    J Chem Neuroanat; 2006 Dec; 32(2-4):90-100. PubMed ID: 16822645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the conversion of haloperidol and its tetrahydropyridine dehydration product to potentially neurotoxic pyridinium metabolites by human liver microsomes.
    Usuki E; Pearce R; Parkinson A; Castagnol N
    Chem Res Toxicol; 1996 Jun; 9(4):800-6. PubMed ID: 8831826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In brown Norway rats, MPP+ is accumulated in the nigrostriatal dopaminergic terminals but it is not neurotoxic: a model of natural resistance to MPTP toxicity.
    Zuddas A; Fascetti F; Corsini GU; Piccardi MP
    Exp Neurol; 1994 May; 127(1):54-61. PubMed ID: 8200437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of organotypic ventral mesencephalic cultures from embryonic mice and protection against MPP toxicity by GDNF.
    Jakobsen B; Gramsbergen JB; Møller Dall A; Rosenblad C; Zimmer J
    Eur J Neurosci; 2005 Jun; 21(11):2939-48. PubMed ID: 15978005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro studies of striatal vesicles containing the vesicular monoamine transporter (VMAT2): rat versus mouse differences in sequestration of 1-methyl-4-phenylpyridinium.
    Staal RG; Hogan KA; Liang CL; German DC; Sonsalla PK
    J Pharmacol Exp Ther; 2000 May; 293(2):329-35. PubMed ID: 10772999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in the disposition and toxicity of 1-methyl-4-phenylpyridinium in cultured rat and mouse astrocytes.
    Tsai MJ; Lee EH
    Glia; 1994 Dec; 12(4):329-35. PubMed ID: 7890335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a pyridinium metabolite derived from haloperidol on the activities of striatal tyrosine hydroxylase in freely moving rats.
    Igarashi K; Matsubara K; Kasuya F; Fukui M; Idzu T; Castagnoli N
    Neurosci Lett; 1996 Aug; 214(2-3):183-6. PubMed ID: 8878114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1-methyl-4-phenylpyridinium (MPP+) analogs: in vivo neurotoxicity and inhibition of striatal synaptosomal dopamine uptake.
    Johnson EA; Wu EY; Rollema H; Booth RG; Trevor AJ; Castagnoli N
    Eur J Pharmacol; 1989 Jul; 166(1):65-74. PubMed ID: 2806366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of phospholipid methylation in 1-methyl-4-phenyl-pyridinium ion (MPP+)-induced neurotoxicity in PC12 cells.
    Lee ES; Chen H; Charlton CG; Soliman KF
    Neurotoxicology; 2005 Dec; 26(6):945-57. PubMed ID: 15950286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of involvement of glutamate-induced excitotoxicity in MPP+ toxicity in striatal dopaminergic terminals: possible involvement of ascorbate.
    Matarredona ER; Santiago M; Machado A; Cano J
    Br J Pharmacol; 1997 Jul; 121(5):1038-44. PubMed ID: 9222565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.